US Patent Issued to BioNTech, TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige on Sept. 15 for "Therapeutic RNA for HPV-positive cancer" (German Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,233, issued on Sept. 15, was assigned to BioNTech SE (Mainz, Germany) and TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige GmbH (Mainz, Germany).

"Therapeutic RNA for HPV-positive cancer" was invented by Ugur Sahin (Mainz, Germany), Sebastian Kreiter (Mainz, Germany), Mustafa Diken (Mainz, Germany), Fulvia Vascotto (Mainz, Germany), Nadja Salomon (Mainz, Germany) and Christian Grunwitz (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to the field of therapeutic RNA to treat HPV-positive cancer, in particular anogenital, cervical and penile cancers a...